UBS Group
MSACW

UBS Group’s Medicus Sciences Acquisition Corp. Warrant MSACW Stock Holding History

UBS Group’s Portfolio MSACW Stock Details MSACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,027
Closed – – 11546
2022
Q3 		$0 Sell
2,027
-399
-16% -$76 ﹤0.01% 11471
2022
Q2 		$0 Sell
2,426
-100
-4% -$28 ﹤0.01% 11453
2022
Q1 		$1K Buy
2,526
+1,776
+237% +$822 ﹤0.01% 10062
2021
Q4 		$1K Buy
750
+611
+440% +$449 ﹤0.01% 10130
2021
Q3 		$0 Buy
+139
New +$127 ﹤0.01% 10418

Other funds holding MSACW

DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

UBS Group's MSACW Position: Q4 2022 in Review

UBS Group sold out of Medicus Sciences Acquisition Corp. Warrant (MSACW) in Q4 2022, closing a stake of 2,027 shares.

UBS Group first reported a position in MSACW in Q3 2021 and held it in 5 quarters. The position peaked at $1K in Q1 2022. 16 funds tracked by Wall St. Rank hold MSACW as of Q4 2022.

  • UBS Group reported no remaining Medicus Sciences Acquisition Corp. Warrant position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 2,027 Medicus Sciences Acquisition Corp. Warrant shares in Q4 2022.
  • UBS Group first reported a position in Medicus Sciences Acquisition Corp. Warrant in Q3 2021 and held it in 5 quarters.
  • UBS Group's Medicus Sciences Acquisition Corp. Warrant position peaked at $1K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.